Mallinckrodt PLC

Mallinckrodt PLC
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
117.34 M
Public Float
-
Mallinckrodt PLC
Stock Exchange New York Stock Exchange
EPS
$41.28
Market Cap
$724.15 M
Shares Outstanding
83.81 M
Public Float
82.28 M

Profile

Address
3 Lotus Park
Staines-Upon-Thames Surrey TW18 3AG
United Kingdom
Employees -
Website http://mallinckrodt.com
Updated 07/08/2019
Mallinckrodt Plc operates as a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments.

Financials

View All
Created with Highcharts 5.0.14Mallinckrodt PLCNet Income. Fiscal year is January-December. All values USD Millions.58583193192352354894891 7711 7713 6223 62220132014201520162017201801k2k3k4k
Created with Highcharts 5.0.14Mallinckrodt PLCSales/Revenue. Fiscal year is January-December. All values USD Millions.2 2052 2052 5402 5402 9232 9233 3813 3813 2223 2223 2163 21620132014201520162017201801k2k3k4k

Angus C. Russell
Chairman
Mark C. Trudeau
President, Chief Executive Officer & Director